Abstract
Tumors can evade conventional T cell recognition by rendering the HLA class I antigen presentation system defective. In a recent study, de Vries et al. reveal γδ T cells as key contributors to the efficacy of immune checkpoint blockade (ICB) against HLA-I-silenced cancers, highlighting a novel layer of surveillance against immune escape by tumors.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 159-161 |
| Number of pages | 3 |
| Journal | Trends in Immunology |
| Volume | 44 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2023 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology